Hideaki Miyake

13.8k total citations
620 papers, 10.8k citations indexed

About

Hideaki Miyake is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Hideaki Miyake has authored 620 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 319 papers in Pulmonary and Respiratory Medicine, 195 papers in Surgery and 173 papers in Molecular Biology. Recurrent topics in Hideaki Miyake's work include Renal cell carcinoma treatment (139 papers), Bladder and Urothelial Cancer Treatments (134 papers) and Prostate Cancer Treatment and Research (115 papers). Hideaki Miyake is often cited by papers focused on Renal cell carcinoma treatment (139 papers), Bladder and Urothelial Cancer Treatments (134 papers) and Prostate Cancer Treatment and Research (115 papers). Hideaki Miyake collaborates with scholars based in Japan, Canada and United States. Hideaki Miyake's co-authors include Masato Fujisawa, Isao Hara, Martin Gleave, Sadao Kamidono, Soichi Arakawa, Hiroshi Eto, Mototsugu Muramaki, Kazuki Yamanaka, Atsushi Takenaka and Toshifumi Kurahashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Hideaki Miyake

600 papers receiving 10.6k citations

Peers

Countries citing papers authored by Hideaki Miyake

Since Specialization

Citations

This map shows the geographic impact of Hideaki Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Miyake more than expected).

Fields of papers citing papers by Hideaki Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Miyake. The network helps show where Hideaki Miyake may publish in the future.

Co-authorship network of co-authors of Hideaki Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Miyake. A scholar is included among the top collaborators of Hideaki Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Miyake. Hideaki Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Fc-gamma receptor IIIA polymorphism on late-onset neutropenia and clinical outcomes in kidney transplant recipients following rituximab induction therapy 2025 ·Clinical and Experimental Nephrology ·(unknown), (unknown), (unknown), Takuya Fujimoto, (unknown), (unknown), Naoki Yokoyama, Takuto Hara, Koji Chiba, Hideaki Miyake	0
2	Toward safe clinical deployment of remote robotic surgery in Japan: five-year validation of the hinotori™ system using 5G wireless communication 2025 ·International Journal of Clinical Oncology ·Takuto Hara, (unknown), (unknown), Shuhei Komatsu, (unknown), (unknown), Akihisa Yao, Yoshihiro Muragaki, Hideaki Miyake	0
3	Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study) 2024 ·International Journal of Urology ·Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, Atsushi Ikeda, Makito Miyake, Koshiro Nishimoto, Yuto Matsushita, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Haruhito Azuma, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Oyama, Atsushi Mizokami, Takashige Abe, (unknown), Haruki Kume	5
4	Preoperative factors predicting poor therapeutic efficacy of holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia 2024 ·LUTS Lower Urinary Tract Symptoms ·Kyohei Watanabe, Atsushi Otsuka, Yuichi Kitagawa, (unknown), (unknown), Yuto Matsushita, Hiromitsu Watanabe, Keita Tamura, Daisuke Motoyama, Toshiki Ito, (unknown), Hideaki Miyake	1
5	Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model 2023 ·Scientific Reports ·Hiromitsu Watanabe, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Takayuki Sugiyama, Atsushi Otsuka, Hideaki Miyake	5
6	Robot‐assisted adrenalectomy using a hinotori surgical robot system: Report of first series of six cases 2023 ·Asian Journal of Endoscopic Surgery ·Daisuke Motoyama, Yuto Matsushita, Hiromitsu Watanabe, Keita Tamura, Atsushi Otsuka, Masato Fujisawa, Hideaki Miyake	29
7	Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma 2023 ·Cancer Diagnosis & Prognosis ·(unknown), Ryo Sato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takeshi Tsutsumi, (unknown), (unknown), (unknown), Hideaki Miyake, (unknown)	0
8	TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma 2023 ·Molecular Cancer Therapeutics ·Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane	1
9	Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101 2023 ·ESMO Open ·Yoshihiko Tomita, Robert J. Motzer, Toni K. Choueiri, Brian I. Rini, Hideaki Miyake, Mototsugu Oya, Laurence Albigès, Mamoru Aizawa, Yoshiko Umeyama, Jing Wang, Alessandra di Pietro, Manuela Schmidinger	6
10	Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial 2023 ·BMJ Open ·Hideaki Miyake, Yasumasa Kakei, Yuzo Nakano, Tomoaki Terakawa, Keiko Miyakoda, Kenichi Harada, Masato Fujisawa	1
11	Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence 2023 ·Diagnostics ·Keita Nakane, Hiromitsu Watanabe, Taku Naiki, Kiyoshi Takahara, Takahiro Yasui, Hideaki Miyake, Ryoichi Shiroki, Takuya Koie	5
12	Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial 2023 ·Cancers ·Kazuhiro Kitajima, Junpei Kuyama, Takashi Kawahara, (unknown), (unknown), Shigeyasu Sugawara, Yumiko Kono, Yukihisa Tamaki, (unknown), (unknown), Kimiteru Ito, Akira Toriihara, Shirô Watanabe, Makoto Hosono, Hideaki Miyake, Shingo Yamamoto, Ryohei Sasaki, Mitsuhiro Narita, Koichiro Yamakado	7
13	Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study 2023 ·International Journal of Urology ·Nobutaka Nishimura, Makito Miyake, (unknown), Tatsuki Miyamoto, Koshiro Nishimoto, Masafumi Oyama, Yuto Matsushita, Hideaki Miyake, Hideo Fukuhara, Keiji Inoue, Keita Kobayashi, Hiroaki Matsumoto, Hideyasu Matsuyama, Tomomi Fujii, Yoshihiko Hirao, Kiyohide Fujimoto	2
14	The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study 2023 ·Cancers ·Taku Naiki, Kiyoshi Takahara, Hiromitsu Watanabe, Keita Nakane, (unknown), Takuya Koie, Ryoichi Shiroki, Hideaki Miyake, Takahiro Yasui	4
15	Treatment strategies and outcomes in a long‐term registry study of patients with high‐risk metastatic hormone‐naïve prostate cancer in Japan: An interim analysis of the J‐ROCK study 2022 ·International Journal of Urology ·Hirotsugu Uemura, (unknown), Atsushi Mizokami, Hideaki Miyake, Hiroji Uemura, Hideyasu Matsuyama, Kazuyoshi Nakamura, Kazutaka Saito, Mutsushi Kawakita, Hideki Takeshita, (unknown), Shintaro Ono, (unknown), (unknown), Toshiyuki Kamoto, Kiyohide Fujimoto	10
16	Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate 2021 ·International Journal of Urology ·Kiyoshi Takahara, Taku Naiki, Toshiki Ito, Keita Nakane, Takuya Koie, Takahiro Yasui, Hideaki Miyake, Ryoichi Shiroki	7
17	Efficacy of Using Three-Tesla Magnetic Resonance Imaging Diagnosis of Capsule Invasion for Decision-Making About Neurovascular Bundle Preservation in Robotic-Assisted Radical Prostatectomy 2013 ·Korean journal of urology ·Kazushi Tanaka, Katsumi Shigemura, Mototsugu Muramaki, Satoru Takahashi, Hideaki Miyake, Masato Fujisawa	17
18	Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence 1999 ·Cancer ·Hideaki Miyake, Isao Hara, Kazuki Yamanaka, Kazuo Gohji, Soichi Arakawa, Sadao Kamidono	71
19	Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence 1999 ·Cancer ·Hideaki Miyake, Isao Hara, (unknown), Kazuo Gohji, Soichi Arakawa, Sadao Kamidono	5
20	Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model. 1999 ·QUT ePrints (Queensland University of Technology) ·Martin Gleave, Anthony W. Tolcher, Hideaki Miyake, Colleen C. Nelson, Robert Brown, Eliana Beraldi, James H. Goldie	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact